semaglutide approval mash πExciting news that is now FDA approved for (aka fatty liver disease) βAt week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Novo Nordisk seeks approval for
Description
BioPharma Services bioanalytical assay utilizes a solid phase extraction procedure (Phenomenex SPE 96 well plate) requiring 200 L of human plasma spiked with stable labeled internal standard (semaglutide-d8)
Patients typically regained approximately two thirds of the weight they had lost within a year of stopping using the medication (1,3)
Thats why the FDA recommends stopping semaglutide at least two months before trying to conceive
The company has been selling the current dosage of semaglutide under the brand name Wegovy
Weight management is rarely a simple balance of diet and exercise alone
